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ABSTRACT
Mubarak Huraysan Almutairi. M.S. Department of Microbiology and Immunology, Wright State
University, 2016. The Impact of HSV-1 Infection, SOCS1 peptide, and SOCS3 peptide mimetic
on Cell Viability, Morphology, and Cytoskeleton Proteins of Unpolarized and Cytokine-Polarized
M1 RAW 264.7 Murine Macrophages
The immune response against HSV-1 involves macrophages in both innate and adaptive
immunity by limiting HSV-1 replication. In this study, the effects of HSV-1 challenge on cell
viability, morphology, and cytoskeletal filament in unpolarized and cytokine-polarized murine
RAW 264.7 macrophages at 24 and 48 hours were monitored. Because the distribution of
cytoskeleton throughout the cell is critical in cell viability and function, effects of HSV-1 challenge
on the organization of F-actin and microtubule (tubulin) in unpolarized and cytokine-polarized
murine RAW 264.7 macrophages were monitored at 24 and 48 hours post infection. F-actin and
tubulin organization were assessed by quantifying the fluorescent intensity of immunofluorescent
images using ImageJ analysis. M1 polarized cells displayed a significant decrease (p, 0.001) in
cell viability when compared to control cells. At 24 and 48 hours post polarization, M1 cells
showed flattened, irregular shapes with intracellular vacuoles, whereas unpolarized control cells
(M0) appeared rounded. Following HSV-1 infection, both M0 and M1 macrophages exhibited a
rounded shape. HSV-1 infection enhanced the organization of F-actin expression by unpolarized
M0 and polarized M1 cells at 24 hours post infection; decreases in F-actin expression for all cells
were observed at 48 hours post infection. The effects of treatments with peptide mimetics of
suppressor of cytokine signaling (SOCS) proteins, namely SOCS1 and SOCS3, on cell viability
and the organization of F-actin and tubulin of uninfected and HSV1-infected unpolarized and
cytokine-polarized murine RAW 264.7 macrophages were evaluated at 24 and 48 hours.
Treatment with a SOCS3 peptide mimetic increased cell viability of polarized M1 and HSV-1infected M1 RAW 264.7 cells, whereas treatments with a SOCS1 peptide mimetic decreased
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viability of these cells. These observations suggest that SOCS3 peptide mimetic functions as an
anti-inflammatory (anti-apoptotic) molecule by preventing cell death. Treatment of HSV-1infected polarized M1 cells with either SOCS1 or SOCS3 peptide mimetic increased tubulin
expression (p<0.001), suggesting that mechanism increased microtubule expression, such as
increasing microtubule stability as a consequence of RhoA GTPases activation by SOCS1 and
SOCS3 proteins.
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HYPOTHESIS
SOCS3 peptide mimetic can cause uninfected and HSV-1 infected, polarized M1 macrophages
(RAW 264.7) to convert to the M2 anti-inflammatory state. This conversion should be
accompanied by of increased levels of IL-10 and decreased levels of TNF-α in supernatant fluids
of the SOCS3 treated cells at 24 after M1 polarization. SOCS1 and SOCS3 peptides will cause
notable differences in the cytoskeletal F-actin and tubulin proteins of HSV-1 infected polarized
and unpolarized cells at 24 and 48 hours.
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INTRODUCTION
Herpes simplex virus type 1 (HSV-1) is one of the most common contagious infections,
and a major cause of illnesses and death in the world (Arduino & Porter, 2016). HSV-1 is an
extremely widespread human virus, and is a member of herpesviruses family. HSV-1 mainly
infects epithelial cells becoming latent in ganglia of sensory neurons (Bello-Morales et al., 2016).
If HSV-1 is reactivated and infection is uncontrolled, HSV-1 may cause oral infections, blindness,
and encephalitis. Furthermore, HSV-1 has become one of the major cause of genital infections
(Ramakrishna et al., 2016). Recent studies suggest that the immune system regulate reactivation
of HSV-1 at the latency site in sensory neurons, and/or control transmission of virus from nerve
cells to the other body tissues. Therefore, improving the mechanisms that preserve the virus in a
latent state in a nerve cell might be advantageous in controlling HSV-1 pathogenesis (Liu et al.,
2016).
Macrophages are phagocytic cells that differentiate from circulating peripheral blood
monocytes, and are present in most tissues. They have a significant function in the immune system,
especially during bacterial and viral infectious diseases. Macrophages have different mechanisms
to protect host immune system against pathogens, for instance, phagocytosis and releasing certain
cytokines and chemokines. Depending upon the immediate environment, macrophages can
activate different phenotypes responsible for a variety of functions. The main two activated
phenotypes are the pro-inflammatory M1 macrophage, and the anti-inflammatory M2 macrophage.
The classical M1-macrophages can be activated by lipopolysaccharide (LPS) and interferon-γ
(IFN-γ), and have antibacterial functions by producing high levels of pro-inflammatory effector
molecules, like interleukins (IL), including IL-1β, IL-6, IL-12, and IL-23, and tumor necrosis
factor. On the other hand, the alternatively activated, anti-inflammatory M2-macrophages are
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divided into three main subgroups, and play an important function in tissue repair and wound
healing by producing a variety of anti-inflammatory cytokines like IL-10 (Wang et al., 2015).
Many recent studies show that during HSV-1 corneal infection, the virus invades sensory neurons
and transmits to the trigeminal ganglion (TG) starting a latent infection in these cells. Many recent
studies show that macrophages and other leukocytes infiltrate the TG during the period of active
HSV-1 replication and release certain cytokines, particularly TNF-α, IFN-γ, the inducible nitric
oxide synthase (iNOS) enzyme, and IL-12 (Kodukula et al, 1999).
The cytoskeleton of eukaryotic cells is made of filamentous proteins, and its functions
include establishing cell shape and providing mechanical strength. Three major filaments form the
cytoskeleton, each part has different structure and protein components. Microtubules represent the
largest filaments of the cytoskeleton, and mainly made of a highly dynamic structure proteins
called tubulin. Microtubules initially form and organized from microtubule organizing centers
(MTOCs), and they play an essential role in the cellular growth and movement, intracellular
transport of organelles, and the chromosomal separation in mitosis. Actin filaments are intertwined
strands filaments composed of g-actin proteins. The actin filaments have characteristics of
remodeling and turnover, which are important in many cellular processes, such as motility,
differentiation, division and membrane organization (Fife et al., 2014). Microtubules with certain
motor proteins, like Kinesin and dynein play an important role in Axoplasmic transport mechanism
that used by HSV-1 to move from cytoplasm into the host cell’s nucleus. Therefore, study the
morphological and structural changes in the cytoskeleton of the HSV-1 infected cell is a
significance method to identify the viral mechanisms of movement along the host cytoskeleton.
Suppressor of cytokine signaling (SOCS) proteins are a family of eight proteins (SOCS1–
7 and cytokine-induced protein (CIS)), and they help to control the release of cytokines in polarized
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macrophages. They negatively regulate the Janus kinase-signal transducer and activator of
transcription (JAK-STAT) signaling pathway (Frey et al., 2009). SOCS1 functions as a negative
feedback regulator to reduce the signaling of certain types of cytokines, particularly IFN-γ
(Hashimoto et al., 2011). Conversely, SOCS3 can be activated by various cytokines, particularly
IL-6/ IL10, and takes an important part in a negative feedback loop to prevent excessive activation
of the signaling pathway (Li et al., 2016).
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LITERATURE REVIEW

Macrophages polarization
Macrophages are "professional" phagocytic cells that are produced by differentiation of
monocytes in the tissues and they show high functional diversity with respect to their
environments. Macrophages have a range of surface receptors recognizing signals that can change
their function and create multiple effector populations making them an important components of
the host immune system (Murray & Wynn, 2011). This capability to change function is referred to
as macrophage polarization.
Researchers have characterized macrophage subtypes as proinflammatory (M1) or antiinflammatory (M2). The development of one phenotype depends upon environmental stimuli. M1
macrophages are activated by IFNγ and LPS, and they secrete proinflammatory cytokines, like
iNOS, and TNF-α (Kigerl et al., 2009) (Figure 1). The classically activated macrophages (M1) are
also defined by a large capacity to present antigen, interleukin-12 (IL-12) and IL-23 production,
produce reactive oxygen intermediates, and a polarized type 1 response. The M1 macrophages
promote host defense against some bacteria, viruses, and protozoa, and they also have a mediating
role in antitumor activity. On the other hand, M2 macrophages are induced by interleukin-4 (IL4) or interleukin-13 (IL-13) (Reichard et al., 2015). M2 macrophages are anti-inflammatory cells
that release molecules, like interleukin-10 (IL-10), and they promote tissue remodeling and
angiogenesis (Kigerl et al., 2009).
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Figure 1: Macrophage activation and polarization. M1 classical macrophages activated by IFNγ
and LPS, and produce TNFα, iNOS, IL-6, and ROS. M1 promote polarized Th1 response and host
defense. M2 are activated by various stimuli, like IL-4 or IL-13, and produce IL-10 for the antiinflammatory response, and wond healing regulation (Reproduced from Bohlson et al., 2015).

Cytoskeleton (Microtubules and Microfilaments)
Microtubules are cellular components responsible for determining the cell's structure, and
they are made of hollow rigid, polar cylinders consist of α-tubulin and β-tubulin heterodimers as
fundamental units (outer diameter of 25 nm). These tubulin heterodimers link together to form
thirteen protofilaments that form the structure of a single microtubule (Howard & Hyman, 2007).
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Alpha and beta tubulins create microtubules through polymerization. Polymerization cannot occur
without the formation of the γ-tubulin ring complexes (γ-TuRCs), or the framework provided by
the gamma form of the tubulin proteins, found in the centrosome or microtubule organization
center (MTOC) (Chaffey et al., 2003).
Microtubules filament play an important role in long-distance transport of cargo to and
from the cell center. They also serve as a transport mechanism for vesicles including the essential
materials to the rest of the cell. Microtubules' rigid core allows microtubule-associated motor
proteins (MAPs) such as Kinesin and Dynein to create force and movement within cilia and
flagella (Vale et al., 1992). Besides being responsible for determining a cell's structure,
microtubules also form the spindle apparatus which is used during mitosis, dividing chromosomes
directly (Geoffrey, 2000). In addition, many microtubules organize as a network among the cell in
different distribution depending on the cell type. The organization of microtubules by microtubule
organizing centers (MTOCs) and their association with certain motor and severing proteins
(kinesin ,dynein) are important for the dynamic instability mechanism of microtubules as well as
microtubule polarity (Döhner et al., 2005).
There are two major motor proteins that associate with microtubules and mediate the direct
transport of cargo within the cells: The highly processive and relatively powerful motor proteins
include kinesins (Plus-end-directed molecules) move cargo to the cell periphery (Miki et al., 2005),
and dyneins (Minus-end transport molecules), which transport cargo from the periphery to the cell
center (Pfister et al., 2006).
Microfilaments are composed of monomer globular actin subunits (G-actin) are linked
together to form two flexible intertwined strands of filamentous actin (F- actin) with outer diameter
of 5 to 9 nm. They organize into few dimensional networks inside the cell to connect the interior
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of the cell with its surroundings, and also assisting cell motility and cell division (Falahzadeh et
al., 2015). In muscle cells, actin filaments are associated with myosin proteins to generate force
leading to muscle contraction (Van et al., 2000).
Actin filaments have a fundamental function in short range movements of cargo within the
cell, particularly in parts that display low density of microtubules (Lyman & Enquist, 2009).
Myosin V (MyoV) and myosin VI ( MyoVI) are the major myosin motor proteins which are
responsible for controlling the directed transport of cargo and protein complexes along actin
filaments ( To and away from the cell surface in case of MyoV, and to the ends of actin filaments
in case of MyoVI) (Krendel & Mooseker, 2005).

Suppressor of Cytokine Signaling Proteins (SOCS)
SOCS are a group of inducible proteins that control the JAK STAT signaling pathway
which is important for mediating the activity of cytokines during macrophage and dendritic cell
regulation. They also have an important role in T cell development and differentiation (Frey et al.,
2009). SOCS consists of eight types, SOCS-1 to SOCS-7 and the cytokine-induced SH2 protein.
SH2 domain and a C-terminal SOCS box represent the main parts of SOCS structure. SOCS-1 and
SOCS-3 have a KIR of 12 amino acids work with SH2 to regulate the activity of JAK STAT
pathway. Therefore, SOCS-1 and SOCS-3 molecules are able to control cytokine function by
inhibiting JAK activity through proteasonal degradation (Croker et al., 2008) (Figure 2).
SOCS-3 mainley induced LPS stimulation in macrophages, SOCS-3 has a crucial role in
regulation of two important cytokines: the pro-inflammatory cytokine IL-6, which has a central
role in regulating inflammatory diseases, and the anti-inflammatory cytokine IL-10 following TLR
stimulation. (Yoshimura, et al., 2007). Recent research has suggested that SOCS-3 inhibits the
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activation of TNF-receptor-associated factor 6 and the growth factor-β (TGFβ)-activated kinase 1
(TAK1), that are important for TLR- and IL-1-induced responses (Frobøse et al., 2006).

Figure 2: A) Structure of SOCS proteins consist of three main parts: SH2 domain, amino terminal
region, and a C-terminal SOCS box. B) JAK–STAT signaling pathway diagram. It activated by
specific cytokines and transfer the phosphorylated group via stat molecules to nucleus for the gene
transcription. SOCS proteins can negative regulate the JAK–STAT signaling pathway through
different mechanisms (Reproduced from Shuai, & Liu 2003).
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SOCS proteins and cytoskeleton
Research up to the present time has emphasized the direct and indirect roles of SOCS
proteins in immune system and infectious diseases. Some studies confirm the interaction between
certain types of SOCS proteins and the cytoskeleton proteins. Zou et al. (2008) found that the
microtubule-associated protein 1S (MAP1S) which is a member of the microtubule-associated
protein 1 (MAP1) family and has a crucial role in microtubule stabilization, is highly expressed in
nervous tissues and has a significant relation to SOCS3 function in macrophage. Overexpressed
MAP1S can increase the translocation of SOCS3 from the nucleus to cytoplasm. After examination
of a MAP1S deficient macrophage, they observed that the negative regulation of STAT3 pathway
by SOCS3 was delayed during the IL-6 signaling suggesting that MAP1S functions as an adaptor
protein for the interaction between SOCS3 protein and microtubule cytoskeleton.

Herpes simplex virus (HSV-1)
HSV-1 is a double-stranded DNA virus belonging to Herpesviridae family (Ryan and Ray,
2004). HSV-1 mainly infects the host oral or genital mucous membrane and penetrating the nerve
cells starting the latent stage (Cunningham et al., 2006). Latent infection lasts for the lifespan of
the host. If the immune system is compromised, the HSV-1 may be reactivated, which leads to a
lytic infection. These infections typically show with a cutaneous disease (Reichard et al., 2015).
Less frequently, more severe HSV-1 cases can result in an infection of the corneal epithelium,
leading to blindness (Jones, 2003).
HSV-1 is a large double stranded, linear DNA genome enclosed inside an icosahedral
protein capsid, which is enveloped in a bilayer of lipid connected to the capsid by means of a
tegument forming the complete structure of HSV-1 virion. HSV-1 generally contains a minimum

9

of 74 genes (or open reading frames, ORFs) within its genome, encoding a variety of proteins
responsible for regulating the virus replication during infection and developing the virus particle
components mainly, the capsid, the tegument and the envelope of the virus (Sigamani et al., 2013)
Forming an opening pore enables HSV-1 to enter the host cell and move to the nucleus.
This process depends on a variety of glycoproteins located on the surface of the virus envelope.
These glycoproteins bind to specific receptors on the cell membrane, fusing the virus envelope
with host cell membrane and forming the opining pore. The virus glycoproteins gD, gB, gC, gH,
and gL found on the surface of the virus envelope play the main role of the viral entry into the host
cell by interacting with the receptors on host cell (Rajcani et al., 2000). In the case of a herpes
virus, the primary binding occur when the viral envelope glycoproteins, glycoprotein C (gC) and
glycoprotein B (gB) bind to a host cell surface particle called heparan sulfate. Glycoprotein D (gD)
provides a stable attachment to one of three specific entry receptors including nectin-1, herpesvirus
entry mediator (HVEM), and 3-O sulfated heparan sulfate. When gD binds to its specific receptor,
they form the viral hemi-fusion state with the membrane. Fusion events are further mediated by
glycoprotein B (gB) and the gH–gL complex, which eventually result in creation of the entry pore
and releasing viral capsid into the cytoplasm (Akhtar & Shukla , 2009) (Figure 3). Next, by using
the retrograde and anterograde mechanism of microtubules, the viral capsid is transported to the
cell nucleus and releases its DNA through the nuclear entry pores, starting the viral genes
transcription process (Wisner et al., 2011).
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Figure 3: A) Human herpes virus structure. B) Entry of HSV-1 within the host cell occur in several
events involving various glycoproteins (Reproduced from Suenaga & Arase, 2015).

Furthermore, HSV-1 secretes infected cell protein 47 (ICP-47) to prevent the activation of
the major antiviral immune cells, cytotoxic T-lymphocytes (CTLs). The inhibition involves
blocking the transporter associated with antigen processing (TAP), which is an essential
component to create the viral epitope presentation with MHC class I. HSVs may continue in an
inactive but persistent form known as latent infection, particularly in neural ganglia (Goldsmith et
al., 1998). However, the virus can be reactivated by some illnesses and stresses and be transmitted
to the original site of infection, causing cutaneous disease (Alsharif, 2015)
The immune response to the HSV-1 infection concerns innate and adaptive immune system cells.
Macrophages have an essential role in controlling HSV-1 replication by targeting and killing the
infected cells or slowing the virus replication (Reichard et al., 2015). Macrophages perform a range
of anti-herpetic actions during the first stage of the HSV-1 infection. The primary response to
HSV-1 is achieved by production of variety of cytokines, especially tumor necrosis factor and type
11

I interferons (IFN), generating a direct antiviral effect and activated the macrophages. The next
response line involves IL12 and other cytokines, which lead to the production IFN-γ mainly by
NK cells (Ellermann-Eriksen, 2005). The activated macrophages and other cells function as a
network to control the HSV-1 replication (Mantovani et al., 2004). The antiviral activity of
macrophages is typically phrased as intrinsic or extrinsic. The intrinsic activity of the resting
macrophages against HSV-1 is high as they are not permissive to viral replication. Macrophages
can protect other cells from infection, and they are a blind end for the infection. Extrinsic activity
relates to the ability of macrophages to inactivate the virus outside of the macrophage and to stop
replication in other cells. Intrinsic antiviral activity is dependent upon differentiation factors and
IFN activity (Ellermann-Eriksen, 2005). The production and regulation of simple toxic substances,
such as NO and ROS is complex in activated macrophages and remains an area of significant
research (Ellermann-Eriksen, 2005; Andrews & Sullivan, 2003).

The impact of HSV on the host cytoskeleton
The distribution of host cytoskeleton plays a critical role in the local transport of different
cargo (organelles, vesicles, viruses, etc.). Microtubules and microfilaments control the transferring
of cargo and cellular organelles. These cytoskeleton complex network with their associated
proteins are important in the viral DNA (ex, HSV-1) transmission to and away from the host cell
nucleus in multiple viral infection stages, particularly during the viral entry, replication, and egress.
(Lyman & Enquist, 2009). So, developing and designing new immunological tests for identifying
the composition and the function of the transported complexes at each stage in the virus life cycle
is a critical progress to control the virus infection.
The impact of HSV on the host cytoskeleton network begins with the binding of virus
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glycoproteins with cell receptors. In the case of HSV infection, both gD and nectin viral
glycoproteins play an important part during the viral fusion within cell’s membrane. Once the viral
nectin proteins bind to the gD viral glycoprotein, the actin-remodeling proteins, particularly Rho
GTPases and Ras are activate and regulate the reorganization of the actin cytoskeleton, and
increase the efficiency of the viral trafficking along microtubules to the nucleus (Lyman & Enquist,
2009) (Figure 4). Therefore, inactivation of the actin-remodeling proteins Rho GTPases and Ras
is a significant way to decrease the transport of virus to the nucleus by decreasing the stability of
microtubules indirectly (Naranatt et al., 2005). Palazzo et al. (2001) found that microtubule
stability are induced by a class of Rho effectors known as the diaphanous- releted formins (DRFs):
mDia and mDia (serum starved 3T3 mouse fibroblasts).
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FIGURE 4: Cytoskeleton remodeling during herpesvirus entry at cell surface. Binding of virus
gB with host cell α3β1 integrin stimulates RhoA and Rac1 GTPases production, and resulting in
microtubule stabilization, facilitating the viral capsids to transport to the host cell nucleus
(Reproduced from Lyman & Enquist, 2009).
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MATERIALS AND METHODS
Cell Line
The RAW 264.7 murine macrophage cell line (from American Type Culture Collection ATCC,
Manassas, VA) is the Abelson murine leukemia virus- induced tumor derived from an adult male
BALB/C mice. According to specific instructions, the RAW 264.7 murine macrophages were
cultured on 100mm x 20mm culture petri plates (from BD Biosciences) with Dulbecco’s Modified
Eagle’s Medium (DMEM; HyClone), 10% fetal bovine serum (heat-inactivated) (from Fisher
Scientific) and 1% penicillin-streptomycin antibiotic (from MP Biomedical, LLC). Cells were
grown in a humidified 5% incubator at 37ºC. Cells were split two to three times every week.
Vero 76 cells (CCL-81, ATCC) which are African green monkey kidney epithelial cells, were used
to propagate the HSV-1 (Syn 17+) (originally supplied by Dr. Nancy Sawtell, Children’s Hospital
Medical Center, Cincinnati, OH) and calculating their titers. In our study, we infected the cells
with 0.1 multiplicity of infection (MOI).

Polarization Induction
RAW 264.7 murine macrophage cells were treated with lipopolysaccharide (LPS) (100 ng/mL)
(from Chondrex) and IFN-λ (20 ng/mL) (from Peprotech) directly once the cells reached a level
of observable confluency ranging from 70-80% in order to induce a M1 phenotype. Cells were
polarized for a total of 24 hours, 48 hours, or 72 hours. The cells were collected from the culture
dishes, for cell viability. Immunofluorescence staining was used to analyze and evaluate the
morphological changes and the immunofluorescence intensities for F-actin and tubulin between
the testing groups.
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Cell Viability
RAW 264.7 murine macrophages were be grown to an observable confluency of approximately
70%. Once 70% confluency are reached via observation, cells were then stimulated with IFNλ/LPS, SOCS1 peptide (35 μM/ml), and SOCS3 peptide (35 μM/ml) with a 0.1 multiplicity of
infection of HSV-1 or without a multiplicity of infection of HSV-1. Cells were incubated for 24
hours or 48 hours. Cells that were untreated served as the control M0. The cells which were grown
on 24-well plates for a period of 24 hours, 48 hours, or 72 hours were collected using cell scraper.
The original supernatants were collected and stored at −80°C for cytokine measurements.
Centrifugation of the new supernatant at 1500 rpm was done for a total of 5 minutes at a
temperature of 4oC. After centrifugation, the supernatant was aspirated. One ml of 10% DMEM
medium was used to suspend the cell pellet and a trypan blue stain (Fisher Scientific) was applied
to the cells at a ratio of 1:2 to determine the cell viability in accordance to the following equation:
% Cell Viability = [Total Viable Cells (Unstained) / Total Cells (Viable + Dead)] X 100

Figure 5: Trypan blue exclusion test (Hemocytometer method). Live cells appear colorless under
microscope, whereas the dead cells stain blue.
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Table 1: Cell viability calculations.
Procedure

Equation

% Cell Viability

[Viable cells / Total cells] X 100

Average viable cell x Dilution Factor x 104

Viable Cells/ml

Dilution Factor

Total Volume (Volume of sample + Volume of diluting liquid) / Volume
of sample

Cytokine Measurements
The frozen supernatants were measured for multiple cytokine concentrations using Luminex
Multiplex Immunoassays (R&D Systems) in accordance with manufacturer’s instructions.

Immunofluorescent Staining
The 12 wells removable silicone cultivation chambers (purchased from Ibidi) were used to grow
RAW 264.7 murine macrophages. Once the level of confluency reached approximately 50%, the
cells were then stimulated with IFN-λ/LPS, SOCS1 peptide (35 μM/ml), and SOCS3 peptide (35
μM/ml) with a 0.1 multiplicity of infection of HSV-1 or without a multiplicity of infection of HSV1. Cells that were untreated served as the control. Cells were incubated for 24 hours, 48 hours, or
72 hours. Aspiration of the culture media immediately followed the incubation period. One percent
(1%) bovine serum albumin suspended in phosphate buffered saline was used to wash the cells (23 times, and 3-5 minutes each time) to remove non adherent cells. After that, cells were fixed with
17

four percent (4%) paraformaldehyde suspended in PBS at room temperature for a total of 15
minutes. cells were then rinsed three consecutive times (for five minutes each time) with 1% BSA
in PBS. at room temperature, Cells were then permeabilized using 0.25% Triton X-100 diluted in
PBS for 5-10 minutes. cells were then rinsed three consecutive times (for five minutes each time)
with 1% BSA in PBS. Next, to prevent cells from partaking in non-specific binding, cells were
blocked with a mixture of 5% Goat serum, 3% BSA, and 0.05% tween for one to two hours at
room temperature. Cells were then rinsed three consecutive times (for a five minute each time)
with 1% BSA in PBS. Primary antibody concentrations and dilutions were assessed using 3% BSA
in PBS (the blocking buffer for the non-specific binding of cells) as demonstrated in Table 2.
Following the application of 3% BSA in PBS containing diluted primary antibodies on the cells,
cells were incubated at a temperature of 4oC throughout the night. After that, one percent (1%)
BSA in PBS was used to rinse the cells three times for approximately three minutes each time (for
a total of nine minutes). Next, cells were incubated in the secondary antibody and Texas RedPhalloidin X (Table 2) for 1–2 hours at room temperature in the dark. The cells were rinsed with
1% BSA in PBS six times (for three to five minutes each time). A drop of hard-set mounting
medium, Vectashield (H-1400) from Vector Laboratories was used to mount the stained cells onto
the microscope slide. An Olympus Epi-fluorescence microscope with a ‘spot’ digital camera was
used to make the observations and visualizations become apparent.
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Table 2: A brief summary of the antibodies and the staining used in immunofluorescence
experiment.

Concentration /
ANTIBODY / STAIN

COMPANY

Action

Dilution
Life
Texas Red-Phalloidin X

1:40

F-actin stain
Technologies

α/β-Tubulin Antibody

Cell Signaling

Primary antibody

Technology

against Tubulin

1:50

Rabbit iGG FAB2 goat anti-rabbit

LifeSpan
1:500

polycolonal antibody

Secondary antibody
BioSciences

Statistical Analysis
Experiments were repeated a minimum of three successive times. Data were gathered and collected
from the experiments to measure cell viability, and the immunofluorescence intensity for Texas
Red-Phalloidin X and microtubules. The statistical significance of experimental control groups
and testing further examined and analyzed the differences between testing and the control groups.
One-way ANOVA was used to analyze the differences between the experimental testing groups
using Sigma Plot 13.0 Software. Statistical significance was measured in accordance to P-values
< 0.05 (less than or equal to 0.05) and the data was depicted as mean + standard error of the mean.

Image Processing and Analysis
The Immunofluorescent images were processed and analyzed in Image J (National Institutes of
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Health, http://Image J.nih.gov/ij/) by accepted quantitative fluorescence procedures within the
microscopy community. The image processing and analysis steps with some described
screenshots.
STEP1: SELECT AND CONVERT THE IMAGE. To analyze an image, open the original
image by ImageJ software and convert the color image into an 8-bit image as shown in the Figure
6.

Figure 6: Opening and converting the image type by Image J.

STEP2: SUBTRACT BACKGROUND. (Image → Process → subtract background), which is a
very important step for measuring image intensity. This process is important to remove the pixel
information from a continuous background. Missing this steps result in false data result when the
intensity of image analyzed.
STEP 3: DETECT EXCLUSION REGIONS, AND ISOLATE THE THRESHOLD (ROI).
Before analyzing the immunofluorescence intensity of an image, the pixel values (bins 0-255, by
histogram) of the exclusion regions (black background and the bright saturated artifacts) must be
20

identified to prevent false fluorescence intensity. Many repeated measurements showed that the
black background represent pixel values from 0-20, and pixel values from 111-255 represent the
bright saturated artifacts. Identifying pixels above or below a particular threshold value can be
done as shown in Figure 7.

Figure 7: Isolating Threshold (ROI) by Image J.

STEP 4: ANALYZING THE IMAGE. The Cell Counter tool was operated to count the number
of cells in each image in order to Regulate the image’s ROI area, and then providing a more
accurate evaluation of the cytoskeleton changes within the cells. In ImageJ, the Image → Analyze
→ Analyze Particles... allows you to define total area for the selected image. The average size of
the area value (Total area / Number of counted cells) for each image that represent
immunofluorescence intensities within the ROI were compared using One-way ANOVA and t test
(Sigma Plot 13.0 Software).
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Figure 8: Analyzing the image by Image J.
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RESULTS

Polarized uninfected and virus-infected macrophages displayed morphological changes
when compared to control macrophages
Macrophages were stimulated for 24 or 48 hours with IFN-γ and LPS to induce the M1 phenotype.
The M1 macrophages displayed different shapes and structures with and without HSV- 1. For the
uninfected group, the polarized M1 macrophages appeared enlarged and flattened with
intracellular vacuoles (increasing with the incubation period), while the control M0 cells appeared
rounded at 24 and 48 hours. On other hand, both HSV-1 infected M0, and HSV-1 infected M1
macrophages displayed a rounded shape at 24 and 48 hours.

Following IFN-γ and LPS, uninfected and virus-infected M1 macrophages showed a
significant decrease in cell viability for 24 and 48 hours
Cell viabilities for M1 macrophages were calculated for both groups (with and without HSV-1
Infection) for 24 and 48 hours, and compared to the cell viabilities of the control M0 macrophages.
The cell viabilities for M1 macrophages at 24 and 48 hours were extremely similar (47%, 39%,
respectively, with p value <0.001) and exhibited a decrease in cell viability compared to M0
control cells. The HSV-1 infected group also showed a significant decrease in the cell viability of
M1 macrophages compared to M0 macrophages. At 24 hours, the cell viability of M1 macrophages
decreased 40% with a p value of p =<0.001. After 48 incubation period, the cell viability of M1
macrophages decreased compared to M0 control (35%) (Figure 17 and Figure 18).
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Following treatment of SOCS3 peptide mimetics, uninfected and virus-infected M1
macrophages showed a significant increase in cell viability when compared to SOCS1 treated
M1 macrophages
Cell viabilities were also measured for polarized M1 and HSV-1-infected M1 RAW 264.7
macrophages after treatment with SOCS1 peptide and SOCS3 peptide mimetics, with the same
cell suspension used in the above experiments for 24 and 48 hours. All experiments results showed
that the SOCS3 peptide mimetic resulted in increase in the cell viability of polarized M1
macrophages compared with SOCS1 treated cells (p<0.001). There was no difference between
infected and uninfected groups (Figure 17 and Figure 18).
Pro- inflammatory cytokine TNF-α was increased in M1 cells compared to M1 cells treated with
SOCS3 peptide mimetic and M0 cells. Furthermore, M1 macrophages treated with SOCS1 peptide
show high levels of TNF-α compared to other cells. However, a decrease in IL-10 production was
observed in M1 cells treated with SOCS1 peptide, while M1 cells treated with SOCS3 peptide
mimetic increased the production of IL-10 compared to M1 cells (Figure 21).

HSV-1 promote the overall formation of F-actin structures in macrophages during the 24
post infection
We quantified the cellular F-actin staining in either HSV-1 infected cells or uninfected cells
including control M0 cells, polarized M1 cells, M1 treated with SOCS1 peptide, and M1 cells
treated with SOCS3 peptide mimetics for 24 and 48 hours. As shown in Figure 19, F-actin staining
of infected cells increased at the 24 hours post infection comparing to the uninfected cells. Both
infected and uninfected groups showed a decrease in the F-actin staining at 48 hours that may
relatively result from decreased cell viability at that time. These two results indicate that HSV-1
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can promote the F-actin structure assembly in macrophage cells during the first hours of infection,
which suggesting that the F-actin play an important role in the HSV-1 movement within the
macrophage cells.

Infected and uninfected polarized M1 macrophages, and SOCS1 treated uninfected cells
displayed a significant decrease in immunofluorescence intensity of microtubules for 24
hours
We quantified the cellular tubulin staining in either HSV-1 infected cells or uninfected cells
including control M0 cells, polarized M1 cells, M1 treated with SOCS1 peptide, and M1 treated
with SOCS3 peptide mimetics for 24 and 48 hours. As shown in Figure 20, tubulin staining of
infected and uninfected polarized M1 macrophage cells and SOCS1 treated uninfected cells
exhibited a significant decrease at 24 hours after polarization and infection.

SOCS1 Peptide and SOCS3 Peptide Mimetics increase the immunofluorescence intensity of
microtubules during the 24 hours of HSV-1 infection
The infected polarized M1 macrophage cells showed a significant increase in tubulin staining after
treating cells with SOCS1 peptide and SOCS3 peptide mimetics for 24 hours post infection. Both
infected and uninfected groups showed a decrease in tubulin staining at 48 hours that may
relatively result from the decrease in the cell viability at that time (Figure 20). These peptides
exhibited a significant increase in tubulin staining of virus infected polarized M1 cells in contrast
to the polarized M1 cells.
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Figure 9: Un-polarized RAW 264.7 macrophage and polarized M1 (treated with SOCS1 peptide
or SOCS3 peptide mimetics) for 24 hours. Actin stained with Texas-Red Phalloidin X (Scale bar
=20 μm).
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Figure 10: Un-polarized RAW 264.7 macrophage and polarized M1 (treated with SOCS1 peptide
or SOCS3 peptide mimetics) for 48 hours. Actin stained with Texas-Red Phalloidin X (Scale bar
=20 μm).
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Figure 11: immunofluorescence images for un-polarized RAW 264.7 macrophage and polarized
M1 (treated with SOCS1 peptide or SOCS3 peptide mimetics) for 24 hours using α / β tubulin
Antibody (Scale bar =20 μm).
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Figure 12: immunofluorescence images for un-polarized RAW 264.7 macrophage and polarized
M1 (treated with SOCS1 peptide or SOCS3 peptide mimetics) for 48 hours using α / β tubulin
Antibody (Scale bar =20 μm).
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Figure 13: HSV-1 infected un-polarized RAW 264.7 macrophage and HSV-1 infected polarized
M1 (treated with SOCS1 peptide or SOCS3 peptide mimetics) for 24 hours. Actin stained with
Texas-Red Phalloidin X (Scale bar =20 μm).
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Figure 14: HSV-1 infected un-polarized RAW 264.7 macrophage and HSV-1 infected polarized
M1 (treated with SOCS1 peptide or SOCS3 peptide mimetics) for 48 hours. Actin stained with
Texas-Red Phalloidin X (Scale bar =20 μm).
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Figure 15: immunofluorescence images for HSV-1 infected un-polarized RAW 264.7
macrophage and HSV-1 infected polarized M1 (treated with SOCS1 peptide or SOCS3 peptide
mimetics) for 24 hours using α / β tubulin Antibody (Scale bar =20 μm).
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Figure 16: immunofluorescence images for HSV-1 infected un-polarized RAW 264.7
macrophage and HSV-1 infected polarized M1 (treated with SOCS1 peptide or SOCS3 peptide
mimetics) for 48 hours using α / β tubulin Antibody (Scale bar =20 μm).
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Figure 17: Cell viability of un-polarized (M0), polarized macrophages M1, polarized
macrophages M1 treated with SOCS 1, and polarized macrophages M1 treated with SOCS 3
peptide Mimetics after 24 hours post polarization and HSV-1 infection. (A) Cells without HSV-1
infection. (B) Cells infected with HSV-1. Each value characterizes mean ± standard error (SE) of
three separate experiments. ***, p ≤ 0.001.
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Figure 18: Cell viability of un-polarized (M0), polarized macrophages M1, polarized
macrophages M1 treated with SOCS 1, and polarized macrophages M1 treated with SOCS 3
peptide Mimetics after 48 hours post polarization and HSV-1 infection. (A) Cells without HSV-1
infection. (B) Cells infected with HSV-1. Each value characterizes mean ± standard error (SE) of
three separate experiments. ***, p ≤ 0.001.
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Figure 19: Quantification of F-actin reorganization in RAW 264.7 macrophage cells with and
without HSV-1 infection. M1 cells induced by IFN-λ and LPS treatments, and treated with Socs1
peptide or Socs3 peptide mimetics. Cells were infected with HSV-1 (MOI = 0.01) for 24 (A) or 48
(B). Cells were fixed, permeabilized, and stained with Texas-Red Phalloidin X. The fluorescence
intensity was analyzed by immunofluorescence microscope and ImageJ software. Each value
characterizes mean ± standard error (SE) of three experiments.
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Figure 20: Quantification of Tubulin reorganization in RAW 264.7 macrophage cells with and
without HSV-1 infection. Cells were polarized with IFN-λ and LPS, and treated with Socs1 peptide
or Socs3 peptide mimetics. Cells infected with HSV-1 (MOI = 0.01) for 24 (A) or 48 (B). Cells
were fixed, permeabilized, blocked and incubated α/β-Tubulin Antibody. The fluorescence
intensity was analyzed by immunofluorescence microscope and ImageJ software. Each value
characterizes mean ± standard error (SE) of three experiments.
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Figure 21: Production of anti-inflammatory IL-10 (A) and pro-inflammatory TNF-α (B) by RAW
264.7 cells 24 hours after polarization. M0 cells, M1 cells, M1 cells treated with SOCS1 peptide,
M1 cells treated with SOCS3 peptide mimetic.
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DISSCUSSION
In this study, M1-polarized RAW 264.7 macrophages appeared flattened, elongated,
adherent, and more vacuolated than uninfected control macrophages. Reichard (2012) suggested
that similar morphological changes in infected and polarized M1 J774.1 macrophages may result
from the disruption of the actin cytoskeleton during the HSV-1 replication stage. Staufenbiel and
colleagues (1986) noted adenovirus, another DNA virus, induced a distinct sequence of
cytoskeletal rearrangement in host cells (TC7 subclone CACO human intestinal cells). These
alterations started at the microtubule and eventually the cytoskeleton became nonpolar and
rounder. Alterations occurred not only in the microtubules but also in actin and intermediate
filaments (Staufenbiel et al., 1986).
Following polarization with IFN-γ and LPS, the M1 macrophages displayed a significant
decrease in the cell viability compared to the control M0 cells (Figure 17, 18). M1 macrophages
function as pro- inflammatory cells producing certain cytotoxic molecules such as TNF-α, nitric
oxide species (iNOS) and reactive oxygen species (ROS). These cytotoxic molecules play an
important role in the decline in cell viability of the M1 phenotype (Schachtele et al., 2010).
SOCS molecules are a family of inducible proteins that control the JAK/STAT signaling
pathway mediating the cytokine production (Frey et. al., 2009). SOCS proteins play a critical role
in controlling the innate intracellular immune response during viral infection. Cell viabilities of
polarized M1 and HSV-1-infected M1 RAW 264.7 macrophages were determined following
treatment with SOCS1 and SOCS3 peptide mimetics for 24 hours. The M1 polarized cells exhibit
a significant increase in cell viability after treatment with SOCS3 peptide mimetic compared to
SOCS1 treated M1 cells (for both infected and uninfected groups) (Figure 17, 18). Alsharif (2015)
found that SOCS3-treated M1 macrophage cell lines (J774.1 and RAW 264.7) exhibited a decrease

39

in the production of inflammatory cytokines (TNF-α and IL-6), and an increase in antiinflammatory IL-10 compared with M2 phenotypes of these cell lines. In this study, M1
macrophage cells treated with SOCS3 peptide mimetic exhibited an increase of anti-inflammatory
IL-10 production and a decrease in pro-inflammatory cytokines TNF-α production compared to
M1 cells. These observations suggested that SOCS3 exerts a critical role in controlling the lytic
effect of M1 cells by stimulating the cells to produce a high level of the anti-inflammatory cytokine
IL-10.
Using flow cytometry, Reichard (2012) found that the ratios of SOCS1/SOCS3 for
polarized J774.1 macrophages suggested differing biological roles for SOCS1 and SOCS3.
Marked elevations in SOCS1 over SOCS3 were seen in the M1 polarized cells (7:1) whereas
elevations in SOCS3 over SOCS1 (2:1) were seen in the M2 polarized cells, suggesting that
SOCS1 expression predominated in the pro-inflammatory M1 cells and the anti-inflammatory
SOCS 3 expression predominated in the M2 polarized cells.
Microtubules and actin filaments are two components of the cytoskeleton in eukaryotic
cells. They provide the structural support and the shape to cells, and are responsible for the majority
of the intracellular transport of organelles. Microtubules grow and shrink to produce enough power
for the intracellular transport of organelles with the help of certain motor proteins. Alpha-tubulin
binds to beta-tubulin forming dimers which bind to GTP to form tubulin; these complexes
dynamically assemble and disassemble but permit microtubules to function as the transport system
for intracellular transport of cargo, such as. HSV-1. The present study involving HSV-1 infection
of the macrophages provides an understanding of the effect of this virus on the microtubule
cytoskeleton during infection. Microtubule reorganization during HSV-1 infection plays an
important role in the intracellular transport of the virus to and from the host cell nucleus (Newcomb
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et al., 2007).
In this study, SOCS1 peptide and SOCS3 peptide mimetics were evaluated for their effects
on microtubules of uninfected and HSV-1-infected M1 polarized RAW 264.7 macrophages.
Treatment with either of these peptide mimetics preserved microtubule integrity in HSV-1-infected
M1 RAW 264.7 cells by 24 hours (p<0.01), but not 48 hours (NS), after polarization and infection
(Figure 20). These significant changes in tubulin assuming may result from an increase of
microtubule stability as a consequence of RhoA activation by SOCS1 and SOCS3 proteins.
Naranatt et al. (2015) found that GTPase RhoA has an important function in modulating the
microtubule dynamics by increasing microtubule stability, increasing viral transport along
microtubules to the nucleus. SOCS1 and SOCS3 proteins activate GTPase RhoA (Stevenson et
al., 2010). Palazzo et al. (2001) found that microtubule stability is induced directly by a class of
Rho effectors known as the diaphanous- releted formins (DRFs): mDia and mDia (serum starved
3T3 mouse fibroblasts).
In the present study, uninfected polarized M1 cells exhibited a significant decrease in
tubulin staining in contrast to M0 control cells (Figure 20). This decline in the florescent intensity
of tubulin may result from the effect of LPS and cytotoxic molecules such as TNF-α on
microtubule dynamics. TNF-α inhibits microtubules assembly (Shivanna et al., 2009).
Also, in the present study, uninfected M1 polarized cells treated with SOCS3 peptide
mimetic exhibited a significant increase in tubulin staining in contrast to untreated polarized M1
cells (Figure 16). These observations are consistent with the study of Zou et al. (2008) that the
microtubule associated protein 1 (MAP1S) has a crucial role in SOCS3 localization to
microtubules and its negative regulating mechanism during cytokine signaling. They found that
the overexpressed MAP1S can increase the translocation of SOCS3 from the nucleus to cytoplasm.
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After examination of a MAP1S deficient macrophage, they observed that the negative regulation
of STAT3 pathway by SOCS3 was delayed during the IL-6 signaling, suggesting that MAP1S
function as an adaptor protein for the interaction between SOCS3 protein and microtubule
cytoskeleton. Another explanation for this phenomenon might be that increase the
immunofluorescence intensity of tubulin may result from the increase in the cell viability of
polarized M1 cells when they treated with SOCS3 peptide mimetics as we found in the result of
this study.
In this study, the effect of these peptide mimetics on F-actin were similarly examined. After
24 hours of infection, F-actin expression was increased in virus-infected unpolarized or polarized
cells where the cells were treated with either of the peptide mimetics (Figure 19). The peptide
mimetics had no effect on F-actin expression but HSV-1 infection did. This increase in F-actin
expression by the infected cells during the first 24 hours suggests that the F-actin structures may
facilitate HSV-1 infection and replication in the macrophage cells. These observations are
supported by those of Xiang and colleagues (2012). They found HSV-1 infection enhanced the
formation of F-actin –based structures in the early infection of a neuroblastoma cell line.
In future studies it would be beneficial to study the morphological changes and the
quantitative immunofluorescence intensities for the cellular cytoskeleton during the early stage
of HSV-1 infection. An in vitro approach would include inducing M1 macrophages treated with
SOCS1 peptide SOCS3 peptide mimetics (or untreated control cells) with or without HSV-1
(MOI of 0.1) for 4, 12, and 18 hours and then evaluating the changes on F-actin and microtubules
via immunofluorescent microscope. Since quantitative analysis of cytoskeletal proteins is
critical for understanding HSV-1 infection, immunoblotting approaches should also be used to
include unpolarized actin (G-actin) and tubulin filaments in assessing total pools of cytoskeletal
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proteins in these cells.
Cell viability studies should include measurements of apoptosis such as immunostaining
for anexin V. Since HSV-1 increases activation of RhoA GTPase proteins that are involved in
regulating actin filaments, tubulin stability, and motor proteins (dynein and kinesin),
immunofluorescent experiments should be included to determine the levels of these molecules
in the cytoplasm of SOS1 and SOC3 treated, uninfected and HSV-1-infectes polarized and
unpolarized RAW 264.7 macrophages.
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